Measurement of the new anticoagulants
New oral anticoagulants are given at fixed daily doses without laboratory dose adjustment for prevention of venous thromboembolism following elective total knee- and hip replacement, for treatment and prevention of recurrent events of acute venous thromboembolism, and for prevention of embolic event...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
7 June 2012
|
| In: |
Thrombosis research
Year: 2012, Volume: 129, Issue: Supplement 1, Pages: S106-S113 |
| ISSN: | 1879-2472 |
| DOI: | 10.1016/S0049-3848(12)70028-2 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/S0049-3848(12)70028-2 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0049384812700282 
|
| Author Notes: | Job Harenberg, Roland Kraemer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1577536800 | ||
| 003 | DE-627 | ||
| 005 | 20230426230636.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180712s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0049-3848(12)70028-2 |2 doi | |
| 035 | |a (DE-627)1577536800 | ||
| 035 | |a (DE-576)507536800 | ||
| 035 | |a (DE-599)BSZ507536800 | ||
| 035 | |a (OCoLC)1341013486 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Harenberg, Job |d 1950- |e VerfasserIn |0 (DE-588)108825507 |0 (DE-627)655891498 |0 (DE-576)339563745 |4 aut | |
| 245 | 1 | 0 | |a Measurement of the new anticoagulants |c Job Harenberg, Roland Kraemer |
| 264 | 1 | |c 7 June 2012 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.07.2018 | ||
| 520 | |a New oral anticoagulants are given at fixed daily doses without laboratory dose adjustment for prevention of venous thromboembolism following elective total knee- and hip replacement, for treatment and prevention of recurrent events of acute venous thromboembolism, and for prevention of embolic events in atrial fibrillation. However, it may be necessary to determine the anticoagulant effect of new oral anticoagulants in special patient populations such as in elderly, for renal impairment, before operation, bleeding or thrombotic episodes and to monitor self-compliance. Oral factor Xa and oral thrombin inhibitors influence dose dependently global and specific coagulation assays. Standardization of assays is currently undertaken. Determination of the new oral anticoagulants in serum samples would facilitate blood sampling and analysis from samples taken and stored for creatinine or other biochemical parameters. Point of care methods from plasma or urine for the new oral anticoagulants would improve patient care. First data demonstrate the feasibility of such assays in urine. | ||
| 650 | 4 | |a Dabigatran | |
| 650 | 4 | |a Factor Xa inhibitors | |
| 650 | 4 | |a Oral anticoagulants | |
| 650 | 4 | |a POCT (Point-of-care-Testing) | |
| 650 | 4 | |a Rivaroxaban | |
| 650 | 4 | |a Thrombin inhibitors | |
| 650 | 4 | |a Urine test | |
| 700 | 1 | |a Krämer, Roland |e VerfasserIn |0 (DE-588)1020469730 |0 (DE-627)691227861 |0 (DE-576)360500331 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Thrombosis research |d Amsterdam [u.a.] : Elsevier Science, 1972 |g 129 (2012, Supplement 1) S106-S113, 8 Seiten |h Online-Ressource |w (DE-627)30671082X |w (DE-600)1500780-7 |w (DE-576)098253263 |x 1879-2472 |7 nnas |a Measurement of the new anticoagulants |
| 773 | 1 | 8 | |g volume:129 |g year:2012 |g number:Supplement 1 |g pages:S106-S113 |g extent:8 |a Measurement of the new anticoagulants |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0049-3848(12)70028-2 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0049384812700282 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180712 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 1020469730 |a Krämer, Roland |m 1020469730:Krämer, Roland |d 120000 |d 120200 |e 120000PK1020469730 |e 120200PK1020469730 |k 0/120000/ |k 1/120000/120200/ |p 2 |y j | ||
| 998 | |g 108825507 |a Harenberg, Job |m 108825507:Harenberg, Job |d 60000 |d 65400 |e 60000PH108825507 |e 65400PH108825507 |k 0/60000/ |k 1/60000/65400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1577536800 |e 3017454673 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"title":[{"subtitle":"vascular obstruction, hemorrhage and hemostasis","title":"Thrombosis research","title_sort":"Thrombosis research"}],"pubHistory":["1.1972 -"],"part":{"year":"2012","issue":"Supplement 1","pages":"S106-S113","text":"129 (2012, Supplement 1) S106-S113, 8 Seiten","volume":"129","extent":"8"},"disp":"Measurement of the new anticoagulantsThrombosis research","note":["Gesehen am 15.11.23"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"30671082X","origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1972","publisher":"Elsevier Science","dateIssuedDisp":"1972-"}],"id":{"issn":["1879-2472"],"eki":["30671082X"],"zdb":["1500780-7"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Job Harenberg, Roland Kraemer"]},"id":{"doi":["10.1016/S0049-3848(12)70028-2"],"eki":["1577536800"]},"origin":[{"dateIssuedDisp":"7 June 2012","dateIssuedKey":"2012"}],"recId":"1577536800","language":["eng"],"note":["Gesehen am 12.07.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"family":"Harenberg","given":"Job","display":"Harenberg, Job","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Roland","family":"Krämer","role":"aut","roleDisplay":"VerfasserIn","display":"Krämer, Roland"}],"title":[{"title_sort":"Measurement of the new anticoagulants","title":"Measurement of the new anticoagulants"}]} | ||
| SRT | |a HARENBERGJMEASUREMEN7201 | ||